PSYCHEMEDICS CORP - PMDI

Sector: Healthcare · Industry: Services-Medical Laboratories
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2024 · Q2 2024
Value (USD)
Total reported value ($000)
$1.716M
QoQ value delta ($000)
+$209K (+13.87%)
Implied price effect (QoQ)
-4.48%
Shares
Total shares
746,273
QoQ shares delta
+120,249 (+19.21%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PMDI)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2024)

Top 25 only Full list
Early Q4 2025 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
RENAISSANCE TECHNOLOGIES LLC 625 270,863 0.0%
VANGUARD GROUP INC 580 251,283 0.0%
BlackRock, Inc. 153 66,408 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 109 47,391 0.0%
GEODE CAPITAL MANAGEMENT, LLC 98 42,679 0.0%
CITADEL ADVISORS LLC 49 21,509 0.0%
DIMENSIONAL FUND ADVISORS LP 48 21,060 0.0%
NORTHERN TRUST CORP 43 18,910 0.0%
MORGAN STANLEY 6 3,001 0.0%
Tower Research Capital LLC (TRC) 4 1,977 0.0%
Provenance Wealth Advisors, LLC 1 772 0.0%
JPMORGAN CHASE & CO 0 11 0.0%
BANK OF AMERICA CORP /DE/ 0 51 0.0%
WELLS FARGO & COMPANY/MN 0 1 0.0%
FMR LLC 0 100 0.0%
OSAIC HOLDINGS, INC. 0 257 0.0%